| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Department of Medicine, University Health Network, Toronto General Hospital [D. J. D.], and Banting and Best Diabetes Centre [R. P. B., B. Y.], University of Toronto, Toronto, Ontario, M5G 2C4 Canada
Chemotherapeutic agents produce cytotoxicity via induction of apoptosis and cell cycle arrest. Rapidly proliferating cells in the bone marrow and intestinal crypts are highly susceptible to chemotherapy, and damage to these cellular compartments may preclude maximally effective chemotherapy administration. Glucagon-like peptide (GLP)-2 is an enteroendocrine-derived regulatory peptide that inhibits crypt cell apoptosis after administration of agents that damage the intestinal epithelium. We report here that a human degradation-resistant GLP-2 analogue, h[Gly2]-GLP-2 significantly improves survival, reduces bacteremia, attenuates epithelial injury, and inhibits crypt apoptosis in the murine gastrointestinal tract after administration of topoisomerase I inhibitor irinotecan hydrochloride or the antimetabolite 5-fluorouracil. h[Gly2]-GLP-2 significantly improved survival and reduced weight loss but did not impair chemotherapy effectiveness in tumor-bearing mice treated with cyclical irinotecan. Furthermore, h[Gly2]-GLP-2 reduced chemotherapy-induced apoptosis, decreased activation of caspase-8 and -3, and inhibited poly(ADP-ribose) polymerase cleavage in heterologous cells transfected with the GLP-2 receptor. These observations demonstrate that the antiapoptotic effects of GLP-2 on intestinal crypt cells may be useful for the attenuation of chemotherapy-induced intestinal mucositis.
This article has been cited by other articles:
|
|
 |
|
  I. Hadjiyanni, K. K. Li, and D. J. Drucker Glucagon-Like Peptide-2 Reduces Intestinal Permeability But Does Not Modify the Onset of Type 1 Diabetes in the Nonobese Diabetic Mouse Endocrinology, February 1, 2009; 150(2): 592 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xue, M. B. Sawyer, C. J. Field, L. A. Dieleman, and V. E. Baracos Nutritional Modulation of Antitumor Efficacy and Diarrhea Toxicity Related to Irinotecan Chemotherapy in Rats Bearing the Ward Colon Tumor Clin. Cancer Res., December 1, 2007; 13(23): 7146 - 7154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Anini, A. Izzo, G. Y. Oudit, P. H. Backx, and P. L. Brubaker Role of phosphatidylinositol-3 kinase-{gamma} in the actions of glucagon-like peptide-2 on the murine small intestine Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1599 - E1606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Wessner, E.-M. Strasser, N. Koitz, C. Schmuckenschlager, N. Unger-Manhart, and E. Roth Green Tea Polyphenol Administration Partly Ameliorates Chemotherapy-Induced Side Effects in the Small Intestine of Mice J. Nutr., March 1, 2007; 137(3): 634 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Martin and J. L. Wallace Gastrointestinal Inflammation: A Central Component of Mucosal Defense and Repair Experimental Biology and Medicine, February 1, 2006; 231(2): 130 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M Sinclair and D. J. Drucker Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential Physiology, October 1, 2005; 20(5): 357 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-A. Kim, M. Kakitani, J. Zhao, T. Oshima, T. Tang, M. Binnerts, Y. Liu, B. Boyle, E. Park, P. Emtage, et al. Mitogenic Influence of Human R-Spondin1 on the Intestinal Epithelium Science, August 19, 2005; 309(5738): 1256 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Koehler, B. Yusta, and D. J. Drucker The HeLa Cell Glucagon-Like Peptide-2 Receptor Is Coupled to Regulation of Apoptosis and ERK1/2 Activation through Divergent Signaling Pathways Mol. Endocrinol., February 1, 2005; 19(2): 459 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Estall and D. J. Drucker Tales beyond the Crypt: Glucagon-Like Peptide-2 and Cytoprotection in the Intestinal Mucosa Endocrinology, January 1, 2005; 146(1): 19 - 21. [Full Text] [PDF]
|
|
|
|
 |
|
 J Thulesen, B Hartmann, K J Hare, H Kissow, C Orskov, J J Holst, and S S Poulsen Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice Gut, August 1, 2004; 53(8): 1145 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Lovshin, Q. Huang, R. Seaberg, P. L. Brubaker, and D. J. Drucker Extrahypothalamic Expression of the Glucagon-Like Peptide-2 Receptor Is Coupled to Reduction of Glutamate-Induced Cell Death in Cultured Hippocampal Cells Endocrinology, July 1, 2004; 145(7): 3495 - 3506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Brubaker and D. J. Drucker Minireview: Glucagon-Like Peptides Regulate Cell Proliferation and Apoptosis in the Pancreas, Gut, and Central Nervous System Endocrinology, June 1, 2004; 145(6): 2653 - 2659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhao, L. Huang, N. Belmar, R. Buelow, and T. Fong Oral RDP58 Allows CPT-11 Dose Intensification for Enhanced Tumor Response by Decreasing Gastrointestinal Toxicity Clin. Cancer Res., April 15, 2004; 10(8): 2851 - 2859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Estall and D. J. Drucker Dual Regulation of Cell Proliferation and Survival via Activation of Glucagon-Like Peptide-2 Receptor Signaling J. Nutr., November 1, 2003; 133(11): 3708 - 3711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Thomas, M. R. Hellmich, C. M. Townsend Jr., and B. M. Evers Role of Gastrointestinal Hormones in the Proliferation of Normal and Neoplastic Tissues Endocr. Rev., October 1, 2003; 24(5): 571 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Walsh, B. Yusta, M. P. DaCambra, Y. Anini, D. J. Drucker, and P. L. Brubaker Glucagon-Like Peptide-2 Receptor Activation in the Rat Intestinal Mucosa Endocrinology, October 1, 2003; 144(10): 4385 - 4392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. L'Heureux and P. L. Brubaker Glucagon-Like Peptide-2 and Common Therapeutics in a Murine Model of Ulcerative Colitis J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 347 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Cameron, P.-C. Yang, and M. H. Perdue Glucagon-like peptide-2-enhanced barrier function reduces pathophysiology in a model of food allergy Am J Physiol Gastrointest Liver Physiol, June 1, 2003; 284(6): G905 - G912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hui, A. Nourparvar, X. Zhao, and R. Perfetti Glucagon-Like Peptide-1 Inhibits Apoptosis of Insulin-Secreting Cells via a Cyclic 5'-Adenosine Monophosphate-Dependent Protein Kinase A- and a Phosphatidylinositol 3-Kinase-Dependent Pathway Endocrinology, April 1, 2003; 144(4): 1444 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker International Union of Pharmacology. XXXV. The Glucagon Receptor Family Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Drucker Glucagon-Like Peptides: Regulators of Cell Proliferation, Differentiation, and Apoptosis Mol. Endocrinol., February 1, 2003; 17(2): 161 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, T. Hansotia, B. Yusta, F. Ris, P. A. Halban, and D. J. Drucker Glucagon-like Peptide-1 Receptor Signaling Modulates beta Cell Apoptosis J. Biol. Chem., January 3, 2003; 278(1): 471 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Yusta, J. Estall, and D. J. Drucker Glucagon-like Peptide-2 Receptor Activation Engages Bad and Glycogen Synthase Kinase-3 in a Protein Kinase A-dependent Manner and Prevents Apoptosis following Inhibition of Phosphatidylinositol 3-Kinase J. Biol. Chem., July 5, 2002; 277(28): 24896 - 24906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D J Drucker Gut adaptation and the glucagon-like peptides Gut, March 1, 2002; 50(3): 428 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nian, J. Gu, D. M. Irwin, and D. J. Drucker Human glucagon gene promoter sequences regulating tissue-specific versus nutrient-regulated gene expression Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R173 - R183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Drucker Glucagon-Like Peptide 2 J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1759 - 1764. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
